Archivo diario: 21 junio, 2016

The National #Parkinson Foundation Announces New Findings from Largest Ever Parkinsons Study Of 8000 Patients Worldwide

The National Parkinson Foundation (NPF) announced today that there are now more than 8,000 people with Parkinson’s disease (PD) enrolled in its Parkinson’s Outcomes Project, the largest-ever clinical study of Parkinson’s disease. The study, which is in its seventh year

Publicado en 2 | Etiquetado | Deja un comentario

New link found between diabetes and #Alzheimer’s disease | EurekAlert! Science News

Drugs used to treat diabetes could also be used to treat Alzheimer’s disease, and vice versa, according to new research from the University of Aberdeen. Curated from New link found between diabetes and Alzheimer’s disease | EurekAlert! Science News

Publicado en 2 | Etiquetado | Deja un comentario

Novel Gene and Cellular Therapy Approaches for Treating #HIV

Advances in HIV drug therapy have drastically decreased mortality and significantly improved quality of life for HIV infected patients since the early days of the epidemic. However, HIV drug-resistance, drug toxicities, therapy adherence, and the need for life-long treatment remain

Publicado en 2 | Etiquetado | Deja un comentario

#Alzheimer’s Care Case Study Sudden Memory Loss or Disorientation in a Person Living with #Dementia | Alzheimer’s Reading Room

When a person living with Alzheimer’s has a sudden drop in memory, or all of sudden seems disoriented, the caregiver assumes this is being caused by Alzheimer’s Disease. But more often than not it is being caused by a bladder

Publicado en 2 | Etiquetado | Deja un comentario

Luz verde al primer ensayo en humanos con una vacuna contra el #Zika #microcefalia

La Agencia Americana del Medicamento (FDA, en sus siglas en inglés) ha autorizado a las compañías Inovio Pharmaceuticals y GeneOne Life Sciences el inicio del primer ensayo clínico en humanos con su vacuna contra el virus Zika. Curated from Luz

Publicado en 2 | Etiquetado | Deja un comentario